×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

North America Cosmetic Surgery Market

ID: MRFR/HC/14649-HCR
128 Pages
Rahul Gotadki
February 2026

North America Cosmetic Surgery Market Research Report Information By Procedure (Surgical Procedures and Non-surgical Procedures), By Gender (Female and Male), By Age Group (18 years and younger, 19 to 34 years, 35 to 50 years, 51 to 64 years and 65 years & above), By Provider (Hospitals & Specialty Clinics and Spas & Cosmetic Surgery Centers) –and North America Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

North America Cosmetic Surgery Market Infographic
Purchase Options

North America Cosmetic Surgery Market Summary

As per Market Research Future analysis, the North America cosmetic surgery market Size was estimated at 21.5 USD Billion in 2024. The North America cosmetic surgery market is projected to grow from 23.15 USD Billion in 2025 to 48.5 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The North America cosmetic surgery market is experiencing a notable shift towards minimally invasive procedures and personalized treatments.

  • The US remains the largest market for cosmetic surgery, driven by a growing acceptance of aesthetic procedures.
  • Canada is emerging as the fastest-growing region, reflecting an increasing demand for non-surgical options.
  • There is a marked trend towards personalization in cosmetic procedures, influenced by social media and consumer preferences.
  • Technological advancements and rising disposable income are key drivers propelling the market forward.

Market Size & Forecast

2024 Market Size 21.5 (USD Billion)
2035 Market Size 48.5 (USD Billion)
CAGR (2025 - 2035) 7.68%

Major Players

Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Hugel (KR), Ipsen (FR), Medytox (KR), Sientra (US), Croma-Pharma (AT)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

North America Cosmetic Surgery Market Trends

The cosmetic surgery market in North America is currently experiencing a dynamic evolution, driven by a combination of technological advancements, changing societal norms, and increasing consumer awareness. The rise of minimally invasive procedures has transformed the landscape, appealing to a broader demographic. Patients are increasingly seeking options that offer quicker recovery times and less visible scarring, which has led to a surge in demand for non-surgical treatments. Furthermore, the influence of social media and celebrity culture appears to play a significant role in shaping public perceptions and desires regarding aesthetic enhancements. As individuals become more informed about available procedures, the market is likely to see continued growth and diversification in offerings. In addition, the cosmetic surgery market is witnessing a shift towards personalized experiences, with practitioners focusing on tailored solutions that meet individual needs. This trend is indicative of a broader movement towards patient-centric care, where the emphasis is placed on understanding and addressing specific concerns. Moreover, the increasing acceptance of cosmetic procedures among various age groups suggests a potential for sustained expansion. As the market adapts to these evolving preferences, it may also face challenges related to regulatory standards and ethical considerations, which will require ongoing attention from stakeholders in the industry.


Rise of Minimally Invasive Procedures


The cosmetic surgery market is seeing a notable increase in the popularity of minimally invasive procedures. These options, which often involve less recovery time and reduced risk of complications, are appealing to a wider audience. As techniques improve, patients are more inclined to choose these alternatives over traditional surgical methods.


Personalization in Cosmetic Procedures


There is a growing trend towards personalized cosmetic procedures, where practitioners tailor treatments to meet the unique needs of each patient. This shift reflects a broader emphasis on patient satisfaction and individualized care, allowing for more effective and targeted outcomes.


Influence of Social Media


Social media platforms are significantly impacting the cosmetic surgery market by shaping public perceptions and desires. The visibility of aesthetic enhancements through influencers and celebrities encourages individuals to consider procedures, thereby driving demand and altering societal norms surrounding beauty.

North America Cosmetic Surgery Market Drivers

Influence of Aging Population

The aging population in North America serves as a pivotal driver for the cosmetic surgery market. As the demographic landscape shifts, a larger segment of the population is seeking cosmetic procedures to address age-related concerns. Reports indicate that individuals aged 50 and above account for nearly 40% of all cosmetic surgeries performed, highlighting the demand for anti-aging treatments. This trend is likely to persist as the baby boomer generation continues to age, with many individuals desiring to maintain a youthful appearance. The increasing focus on health and wellness among older adults further amplifies this demand, as they seek procedures that enhance their quality of life. Consequently, the cosmetic surgery market is expected to adapt and expand its offerings to cater to this growing demographic, ensuring that it meets the evolving needs of an aging clientele.

Expansion of Non-Surgical Options

The expansion of non-surgical options within the cosmetic surgery market is a notable trend that is reshaping consumer preferences. Treatments such as injectables, fillers, and skin rejuvenation procedures have gained immense popularity due to their minimal downtime and lower costs compared to traditional surgical options. Recent statistics reveal that non-surgical procedures now account for over 60% of the total cosmetic procedures performed, indicating a significant shift in consumer choice. This trend is particularly appealing to younger demographics who may be hesitant to undergo invasive surgeries. As practitioners continue to innovate and improve non-surgical offerings, the market is likely to see sustained growth. The increasing availability and acceptance of these alternatives suggest that the cosmetic surgery market will continue to evolve, catering to a broader audience seeking effective yet less invasive solutions.

Increasing Acceptance of Cosmetic Procedures

The growing acceptance of cosmetic procedures among various demographics is a notable driver in the cosmetic surgery market. As societal norms evolve, more individuals view cosmetic enhancements as a means of self-improvement rather than vanity. This shift is particularly evident among younger generations, with a reported increase of 30% in procedures among individuals aged 18-34 in recent years. The normalization of cosmetic surgery through media representation and celebrity endorsements further contributes to this trend. As acceptance rises, the market is likely to expand, with more individuals seeking surgical and non-surgical options to enhance their appearance. This cultural shift not only influences consumer behavior but also encourages practitioners to innovate and diversify their offerings, thereby stimulating growth in the cosmetic surgery market.

Rising Disposable Income and Consumer Spending

The increase in disposable income among consumers in North America is a significant driver of the cosmetic surgery market. As individuals experience higher earnings, they are more inclined to invest in personal aesthetics. Recent data indicates that consumer spending on cosmetic procedures has risen by approximately 15% over the past few years, reflecting a growing willingness to allocate funds towards enhancing one's appearance. This trend is particularly pronounced among middle to upper-income brackets, where individuals prioritize self-care and personal image. The correlation between economic prosperity and spending on cosmetic enhancements suggests that as the economy continues to improve, the cosmetic surgery market may experience sustained growth. This financial empowerment allows consumers to explore a wider range of options, further fueling demand for various cosmetic procedures.

Technological Advancements in Surgical Techniques

Technological advancements play a crucial role in shaping the cosmetic surgery market. Innovations such as 3D imaging, robotic-assisted surgery, and minimally invasive techniques have transformed the landscape of cosmetic procedures. These advancements not only enhance the precision and safety of surgeries but also reduce recovery times, making procedures more appealing to potential clients. For instance, the introduction of laser technology has led to a 25% increase in the popularity of skin resurfacing treatments. As technology continues to evolve, it is expected that the market will witness further growth, with new techniques emerging that cater to the demands of a more informed and discerning clientele. This ongoing evolution in surgical technology is likely to drive competition among practitioners, ultimately benefiting consumers in the cosmetic surgery market.

Market Segment Insights

By Procedure: Surgical Procedures (Largest) vs. Non-Surgical Procedures (Fastest-Growing)

In the North America Cosmetic Surgery Market, surgical procedures constitute the largest segment, capturing a significant portion of the market share. This category includes various procedures such as liposuction, rhinoplasty, and breast augmentation, which have been traditionally sought after by individuals aiming for permanent and noticeable enhancements. Non-surgical procedures, which include Botox injections, dermal fillers, and laser treatments, are witnessing rapid growth as they offer less invasive options with shorter recovery times, thereby appealing to a broader demographic.

Surgical Procedures (Dominant) vs. Non-Surgical Procedures (Emerging)

Surgical procedures have long been the dominant force in the North America Cosmetic Surgery Market, known for their ability to deliver substantial and transformative results. Procedures such as facelift surgeries or breast implants are sought after by patients desiring long-lasting changes. However, non-surgical procedures are emerging as a rapidly growing alternative, favored for their convenience and minimal invasiveness. As technology advances, non-surgical treatments are becoming more effective, attracting a younger audience who prefer to avoid the downtime associated with surgeries. This shift reflects changing consumer preferences towards quicker, more accessible beauty enhancement solutions, making both segments critical in shaping the future landscape of the cosmetic surgery industry.

By Gender: Female (Largest) vs. Male (Fastest-Growing)

In the North America Cosmetic Surgery Market, the female demographic represents the largest share, driven by a historical and cultural emphasis on beauty and aesthetics among women. Female patients typically account for the majority of procedures, such as breast augmentations, liposuction, and facelifts, as they seek both enhancement and restoration. Meanwhile, the male segment is gaining traction, albeit from a smaller base, as societal norms shift and male patients increasingly seek cosmetic interventions for aesthetic and confidence purposes.

Gender: Female (Dominant) vs. Male (Emerging)

Females in the North America Cosmetic Surgery Market are the dominant segment, primarily driven by their strong desire for self-improvement and societal pressures regarding appearance. This segment tends to be the most invested in various cosmetic procedures, leveraging advancements in technology to achieve desired results. On the other hand, the emerging male segment is showing rapid growth as more men embrace aesthetic procedures, breaking down traditional stereotypes around masculinity. This shift is facilitated by rising awareness and acceptance of cosmetic enhancements, leading to increased demand for male-targeted treatments such as minimally invasive procedures. The male segment's growth is characterized by its younger demographic, who are more open to exploring cosmetic surgery options.

By Age Group: 19 to 34 years (Largest) vs. 35 to 50 years (Fastest-Growing)

In the North America Cosmetic Surgery Market, the age distribution indicates that individuals aged 19 to 34 years hold the largest market share, representing a significant portion of the cosmetic surgery demographic. This age group is notably enthusiastic about aesthetic enhancements, significantly influencing the trends and preferences within the market. Conversely, the 35 to 50 years segment is emerging as the fastest-growing, as more individuals within this age range seek procedures aimed at rejuvenation and enhancing their appearance, particularly driven by cultural shifts towards self-care and the normalization of cosmetic solutions.

19 to 34 years (Dominant) vs. 35 to 50 years (Emerging)

The 19 to 34 years age group is characterized by a propensity for cosmetic surgeries that cater to contemporary beauty standards shaped by social media influences. This demographic often opts for minimally invasive procedures, including fillers and laser treatments, focused on enhancing their features with subtlety. Meanwhile, the 35 to 50 years segment is increasingly gaining traction, focusing on procedures that emphasize anti-aging benefits. Individuals in this cohort seek surgical and non-surgical treatments that provide significant results, driving their rapid growth. The blend of innovation in cosmetic techniques and the growing acceptance of cosmetic enhancements among older adults positions this age group as a key player in the market.

By Provider: Hospitals & Specialty Clinics (Largest) vs. Spas & Cosmetic Surgery Centers (Fastest-Growing)

The North America Cosmetic Surgery Market exhibits a notable distribution of market share among its provider segments. Hospitals and specialty clinics hold the largest share, primarily due to their established reputation and comprehensive service offerings. These facilities typically provide a wide range of cosmetic procedures, backed by qualified medical professionals, thus instilling confidence in prospective patients. Meanwhile, spas and cosmetic surgery centers are rapidly gaining traction, reflecting an increasing consumer preference for less invasive procedures and aesthetic enhancements in a more relaxed setting. Growth trends in the provider segment are significantly influenced by evolving consumer attitudes towards cosmetic procedures. The trend towards minimally invasive and non-surgical options has propelled spas and cosmetic surgery centers to the forefront, attracting a younger demographic. Moreover, marketing strategies emphasizing luxury experiences and personalized services are enabling these centers to rapidly expand their clientele. As such, while hospitals and specialty clinics maintain dominance, the dynamic growth of the spa segment indicates shifting consumer preferences and an evolving market landscape.

Hospitals & Specialty Clinics (Dominant) vs. Spas & Cosmetic Surgery Centers (Emerging)

Hospitals and specialty clinics represent the dominant force in the North America Cosmetic Surgery Market, renowned for their extensive surgical capabilities and stringent safety standards. They offer a comprehensive array of procedures and boast highly trained professionals, making them the preferred choice for patients seeking serious cosmetic surgeries. Conversely, spas and cosmetic surgery centers are emerging players, appealing to consumers with a growing interest in non-invasive treatments and aesthetic enhancements. These centers often provide a more relaxed environment and cater to a clientele seeking convenience and luxury, further driving their popularity. The adaptability of spas in marketing innovative procedures positions them as key contenders in capturing the evolving preferences of cosmetic surgery consumers.

Get more detailed insights about North America Cosmetic Surgery Market

Regional Insights

US : Leading Market with Diverse Offerings

The US cosmetic surgery market holds a commanding 18.0% share, valued at approximately $18 billion in 2024. Key growth drivers include increasing consumer awareness, advancements in technology, and a rising trend towards minimally invasive procedures. Regulatory support from the FDA and various state health departments has fostered a favorable environment for innovation. Additionally, robust healthcare infrastructure and a high concentration of skilled professionals contribute to the market's expansion.

Canada : Expanding Demand for Aesthetic Procedures

Canada's cosmetic surgery market, with a 3.5% share, is valued at around $3.5 billion as of 2024. The growth is fueled by increasing disposable incomes, a shift in societal norms towards aesthetic enhancement, and a growing aging population seeking rejuvenation. Government regulations are becoming more supportive, with Health Canada ensuring safety and efficacy in cosmetic products. The market is also benefiting from improved healthcare facilities and training programs for practitioners.

North America Cosmetic Surgery Market Regional Image

Key Players and Competitive Insights

The North American cosmetic surgery market is characterized by a dynamic competitive landscape, driven by a confluence of innovation, consumer demand for aesthetic enhancements, and the increasing acceptance of cosmetic procedures. Key players such as Allergan (US), Revance Therapeutics (US), and Galderma (CH) are at the forefront, each adopting distinct strategies to solidify their market positions. Allergan (US), known for its flagship product Botox, continues to focus on innovation and product diversification, while Revance Therapeutics (US) emphasizes its commitment to developing advanced neuromodulators and dermal fillers, thereby enhancing its competitive edge. Galderma (CH), on the other hand, is leveraging strategic partnerships to expand its product offerings and market reach, indicating a trend towards collaborative growth in the sector.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Allergan (US) and Galderma (CH) suggests a trend towards consolidation, as these firms seek to leverage economies of scale and enhance their competitive positioning.

In October Allergan (US) announced the launch of a new line of minimally invasive facial rejuvenation products, aimed at capturing the growing demand for non-surgical options. This strategic move not only diversifies Allergan's product portfolio but also positions the company to capitalize on the increasing consumer preference for less invasive procedures, potentially driving significant revenue growth in the coming years.

In September Revance Therapeutics (US) secured a partnership with a leading aesthetic clinic chain to expand the distribution of its innovative DaxibotulinumtoxinA injection. This collaboration is likely to enhance Revance's market penetration and brand visibility, reinforcing its position as a key player in the cosmetic surgery market. The partnership underscores the importance of strategic alliances in navigating the competitive landscape.

In August Galderma (CH) launched a sustainability initiative aimed at reducing its carbon footprint across its manufacturing processes. This initiative not only aligns with global sustainability trends but also enhances Galderma's brand reputation among environmentally conscious consumers, potentially attracting a new demographic to its product offerings.

As of November the competitive trends in the cosmetic surgery market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in product development and marketing strategies. Strategic alliances are playing a crucial role in shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet the sophisticated demands of consumers.

Key Companies in the North America Cosmetic Surgery Market include

Industry Developments

  • Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults Allergan Aesthetics, an AbbVie company, received FDA approval for Skinvive™ by JUVÉDERM®, a hyaluronic acid microdroplet injectable, for improving cheek skin smoothness in adults in the United States.
  • Q2 2024: Cutera Appoints Taylor Harris as Chief Executive Officer Cutera, Inc., a provider of aesthetic and dermatology solutions, announced the appointment of Taylor Harris as its new Chief Executive Officer, effective May 2024.
  • Q2 2024: Revance Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia, expanding its neuromodulator portfolio in the U.S. market.
  • Q1 2024: Sientra Announces FDA Approval of New Breast Implant Manufacturing Facility in Wisconsin Sientra, Inc. received FDA approval for its new breast implant manufacturing facility in Wisconsin, aiming to increase production capacity and meet growing demand in the North American cosmetic surgery market.
  • Q1 2024: Alastin Skincare Launches New Procedure Enhancement System for Post-Cosmetic Surgery Recovery Alastin Skincare, a Galderma company, launched a new Procedure Enhancement System designed to support post-cosmetic surgery recovery, targeting clinics and patients in North America.
  • Q2 2024: Allergan Aesthetics Launches JUVÉDERM® VOLUX™ XC for Jawline Enhancement in the U.S. Allergan Aesthetics announced the U.S. launch of JUVÉDERM® VOLUX™ XC, a hyaluronic acid-based injectable gel for jawline enhancement, expanding its facial aesthetics portfolio.
  • Q2 2024: Cutera Launches AviClear™ Acne Device in North America Cutera, Inc. launched AviClear™, a new energy-based device for the treatment of mild to severe acne, in North America, targeting dermatology and cosmetic surgery clinics.
  • Q1 2024: Galderma Announces U.S. FDA Approval of Restylane® Eyelight for the Treatment of Undereye Hollows Galderma received FDA approval for Restylane® Eyelight, a hyaluronic acid filler for the treatment of undereye hollows, expanding its injectable product offerings in the U.S.
  • Q2 2024: Soliton, Inc. Announces Partnership with Aesthetic Solutions for Rapid Acoustic Pulse Technology Soliton, Inc. entered into a partnership with Aesthetic Solutions to distribute its Rapid Acoustic Pulse technology for cellulite and tattoo removal in North America.
  • Q1 2024: Venus Concept Announces FDA Clearance of Venus Bliss Max™ for Non-Invasive Lipolysis Venus Concept received FDA clearance for Venus Bliss Max™, a new device for non-invasive lipolysis of the abdomen and flanks, targeting cosmetic surgery providers in North America.
  • Q2 2024: InMode Ltd. Launches EmpowerRF Platform for Women’s Health and Wellness in the U.S. InMode Ltd. launched EmpowerRF, a new platform for women’s health and wellness procedures, including minimally invasive cosmetic treatments, in the U.S. market.
  • Q1 2024: Apyx Medical Receives FDA 510(k) Clearance for Renuvion® APR Handpiece for Dermal Resurfacing Apyx Medical Corporation received FDA 510(k) clearance for its Renuvion® APR Handpiece, expanding its portfolio of devices for dermal resurfacing procedures in the U.S.

Future Outlook

North America Cosmetic Surgery Market Future Outlook

The cosmetic surgery market is projected to grow at a 7.68% CAGR from 2025 to 2035, driven by technological advancements, increasing consumer awareness, and rising disposable incomes.

New opportunities lie in:

  • Expansion of telemedicine consultations for pre-surgery assessments. Development of minimally invasive procedures to attract younger demographics. Partnerships with wellness brands for bundled service offerings.

By 2035, the market is expected to be robust, driven by innovation and evolving consumer preferences.

Market Segmentation

North America Cosmetic Surgery Market Gender Outlook

  • Female

  • Male

North America Cosmetic Surgery Market Provider Outlook

  • Hospitals & Specialty Clinics

  • Spas & Cosmetic Surgery Centers

North America Cosmetic Surgery Market Age Group Outlook

  • 18 years & younger

  • 19 to 34 years

  • 35 to 50 years

  • 51 to 64 years

  • 65 years & above

North America Cosmetic Surgery Market Procedure Outlook

  • Surgical Procedures

  • Non-Surgical Procedures

Report Scope

MARKET SIZE 2024 21.5(USD Billion)
MARKET SIZE 2025 23.15(USD Billion)
MARKET SIZE 2035 48.5(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.68% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Hugel (KR), Ipsen (FR), Medytox (KR), Sientra (US), Croma-Pharma (AT)
Segments Covered Procedure Type, End User
Key Market Opportunities Integration of advanced technologies enhances patient experience and expands service offerings in the cosmetic surgery market.
Key Market Dynamics Rising consumer demand for minimally invasive procedures drives innovation and competition in the cosmetic surgery market.
Countries Covered US, Canada
Author
Author Profile
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Leave a Comment

FAQs

What is the current valuation of the North America Cosmetic Surgery Market?

<p>The market valuation was 20.2 USD Billion in 2024.</p>

What is the projected market size for the North America Cosmetic Surgery Market by 2035?

<p>The market is projected to reach 32.79 USD Billion by 2035.</p>

What is the expected CAGR for the North America Cosmetic Surgery Market during the forecast period 2025 - 2035?

<p>The expected CAGR is 4.5% during the forecast period 2025 - 2035.</p>

Which companies are considered key players in the North America Cosmetic Surgery Market?

<p>Key players include Allergan, Galderma, Revance Therapeutics, Medytox, Hugel, Ipsen, and Sientra.</p>

How do surgical and non-surgical procedures compare in terms of market valuation?

<p>Surgical procedures were valued at 10.1 USD Billion in 2024, while non-surgical procedures reached 10.1 USD Billion.</p>

What is the market valuation for cosmetic surgery procedures by gender?

In 2024, the market valuation was 12.1 USD Billion for females and 8.1 USD Billion for males.

How does the age distribution affect the North America Cosmetic Surgery Market?

In 2024, the age group 19 to 34 years had a valuation of 5.0 USD Billion, while those aged 51 to 64 years reached 4.0 USD Billion.

What are the primary providers of cosmetic surgery services in North America?

Hospitals and specialty clinics had a market valuation of 10.1 USD Billion, while spas and cosmetic surgery centers reached 10.1 USD Billion in 2024.

What is the projected growth for the non-surgical procedures segment by 2035?

The non-surgical procedures segment is expected to grow from 10.1 USD Billion in 2024 to 17.79 USD Billion by 2035.

What trends are influencing the North America Cosmetic Surgery Market?

Trends indicate a growing preference for non-surgical procedures, particularly among younger demographics, as evidenced by the projected increase in market valuations.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions